BREAKING NEWS: Dow Sheds Triple Digits as Post-Election Rally Cools
Toggle navigation
About Us
Who We Are
About Bernie Schaeffer
Our Newsroom
FAQ
Contact Us
Corrections
Ethics & Fact Checks Policy
Market News
Sign Up for Free Market Newsletters
Opening View
Midday Market Check
Market Recap
View All Free Subscriptions
Schaeffer's Volatility Scorecard
Featured Publication
From the Top
Monday Morning Outlook
Indicator of the Week
Editor's Picks
View All
Trading Analysis
Best & Worst Stocks
Earnings Preview
Investor Sentiment
Quantitative Analysis
Technical Analysis
VIX & Volatility
View All
Stock Options
Intraday Options Activity
Most Active Options
Trade Postmortems
Options Recommendations
View All
Trading Education
Strategies & Concepts
Expectational Analysis
View All
Market News
Buzz Stocks
Stocks on the Move
Analyst Update
5 Minute Market Rundown
Stock Market Podcasts
View All
Daily Market Newsletters
Opening View
Midday Market Check
Market Recap
View All
Trade Alerts
All Trading Services
Most Popular Services
Elite Trader
Quick-Hit Trader
Lightning Trader
Ultimate Trader
View All
Directional Trading
Options Under $5
Leverage
Weekly Options Trader
Event Trader
PowerTrend
Schaeffer's Players
Overnight Trader
View All
Advanced Trading Alerts
Wealthbuilder
Premium Trader
Hedge Hunter
Volatility Trader
Weekly Volatility Trader
View All
Weekend Alert
Weekend Player
Weekend Trader Alert
Expiration Week Countdown
Weekly Options Countdown
View All
Newsletter Trading Services
Master Portfolio
The Option Advisor
Schaeffer's Daily Bulletin
View All
Courses & Education
Getting Started with Options
View All
Options 101
Deals
Deal of the Week
Broker Center
Free Trial
Log-In
Search
content-search-index
Tag: ABBV
ABBV
5
SEARCH RESULTS FOR: "Tag: ABBV"
REFINE YOUR SEARCH
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2022
(2)
2021
(4)
2020
(3)
2019
(6)
2018
(10)
2017
(4)
2016
(2)
2015
(4)
2014
(5)
CATEGORIES
5-Minute Market Rundown
(1)
Analyst Downgrades
(1)
Analyst Update
(3)
Analyst Upgrades
(1)
Bernie's Content
(1)
Buzz Stocks
(9)
By the Numbers
(1)
Earnings Preview
(1)
Editor's Pick
(1)
Expectational Analysis
(1)
General
(6)
Indicator of the Week
(1)
Intraday Option Activity
(1)
Midday Market Check
(2)
Opening View
(4)
Quantitative Analysis
(1)
Stocks On the Move
(6)
Technical Analysis
(2)
Trade Postmortem
(1)
Unusual Trading Activity
(1)
A Dose of AbbVie Stock Can Help Your Bear Market Portfolio
https://www.schaeffersresearch.com/content/marketbeat/2022/07/20/A-Dose-of-AbbVie-Stock-Can-Help-Your-Bear-Market-Portfolio-
7/20/2022 1:00 AM
A growing dividend and expanding pipeline are two reasons to invest in ABBV stock AbbVie ( NYSE: ABBV ) is a conventional stock for unconventional times. And that’s exactly why it makes sense to a...
The Worst Stock to Buy This January
https://www.schaeffersresearch.com/content/bgs/2022/01/07/the-worst-stock-to-buy-this-january
1/7/2022 10:23 AM
As we say welcome in the New Year with cautious optimism, it’s important to note not just the best stock picks to bet on, but also the ones to avoid. Historically, there are a notable amount of names ...
Special Report: Avoid These Two Healthcare Stocks
https://www.schaeffersresearch.com/content/analysis/2021/10/12/special-report-avoid-these-two-healthcare-stocks
10/12/2021 3:04 PM
Last month was a doozy for investors. We've discussed how investors can manage September seasonality ad nauseam, but what about the other side of the coin? What stocks out there could fall victim to ...
Inflation Fears, Funding Stalemate Cap Off September Slide
https://www.schaeffersresearch.com/content/news/2021/10/01/inflation-fears-funding-stalemate-cap-off-september-slide
10/1/2021 3:01 PM
If you're an investor, you're probably sick of the words 'September seasonality' by now. As the historically bearish period came to a close and ushered in a new month, all eyes were on Congress and ...
AbbVie Stock Rises After FDA Approves 3rd Headache Drug
https://www.schaeffersresearch.com/content/news/2021/09/29/abbvie-stock-rises-after-fda-approves-3rd-headache-drug
9/29/2021 10:02 AM
The U.S. Food and Drug Administration (FDA) just approved AbbVie Inc's (NYSE:ABBV) migraine prevention treatment, marking the company's third drug in its roster for severe headaches. The once-daily o...
LOAD MORE
PEOPLE ALSO SEARCH FOR
AAPL
abbv
ABBV
AGN
AMGN
AZN
CLSD
CVX
DJI
ESRX
F
gmab
HON
IDRA
-intraday-options-activity
IXIC
JBLU
lcid
lit
LLY
MCD
MRK
NBIX
NIO
NYSE-ABBV
QURE
RGNX
SPX
TDOC
TM
VYGR
XOM